Tianjin Key Laboratory of Metabolic Diseases, Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
Tianjin Institute of Cardiovascular Disease, Tianjin Chest Hospital, Tianjin, China.
FASEB J. 2018 Dec;32(12):6525-6536. doi: 10.1096/fj.201800248RR.
Endothelial progenitor cell (EPC) dysfunction contributes to diabetes-induced delay in endothelium repair after vessel injury, prominently associated with diabetic cardiovascular complications such as neointima formation. ATP-binding cassette transporter G1 (ABCG1) promotes cholesterol efflux to HDL, which may favorably affect EPC function. However, whether ABCG1 improves EPC function, especially in diabetes, remains unknown. Here we investigated the role of ABCG1 in EPCs by using Tie2-mediated ABCG1 transgenic (Tie2- ABCG1) mice. Mice were injected with streptozotocin to induce diabetes mellitus. As compared with wild-type (WT) mice, in Tie2- ABCG1 mice, diabetes-impaired EPC migration and tube formation were reversed. In vitro gain-of-function and loss-of-function studies further revealed that ABCG1-overexpressing EPCs showed increased migration and tube formation and differentiation via the Lck/Yes-related novel protein tyrosine kinase /Akt/endothelial NO synthase pathway by enhancing cellular cholesterol efflux. Finally, type 1 and type 2 diabetic mouse models with arterial injury were intravenously injected with labeled EPCs from WT or Tie2- ABCG1 mice. Re-endothelialization in diabetic mice was improved to a greater extent by injection of ABCG1-overexpressing than WT EPCs. Our study demonstrated that ABCG1 in EPCs improved repair after vascular injury in diabetes by increasing EPC function such as migration, tube formation and differentiation, and subsequent re-endothelialization. ABCG1 might be a promising therapeutic target for diabetes-associated vascular diseases.-Shi, Y., Lv, X., Liu, Y., Li, B., Liu, M., Yan, M., Liu, Y., Li, Q., Zhang, X., He, S., Zhu, M., He, J., Zhu, Y., Zhu, Y., Ai, D. Elevating ATP-binding cassette transporter G1 improves re-endothelialization function of endothelial progenitor cells via Lyn/Akt/eNOS in diabetic mice.
内皮祖细胞 (EPC) 功能障碍导致糖尿病患者血管损伤后内皮修复延迟,这与糖尿病心血管并发症如新生内膜形成密切相关。三磷酸腺苷结合盒转运体 G1(ABCG1)促进胆固醇向高密度脂蛋白的流出,这可能对 EPC 功能产生有利影响。然而,ABCG1 是否改善 EPC 功能,特别是在糖尿病中,仍不清楚。在这里,我们通过使用 Tie2 介导的 ABCG1 转基因(Tie2-ABCG1)小鼠研究了 ABCG1 在 EPC 中的作用。小鼠注射链脲佐菌素诱导糖尿病。与野生型 (WT) 小鼠相比,在 Tie2-ABCG1 小鼠中,糖尿病损伤的 EPC 迁移和管形成得到逆转。体外功能获得和功能丧失研究进一步表明,ABCG1 过表达的 EPC 通过增强细胞胆固醇流出,通过 Lck/Yes 相关的新型蛋白酪氨酸激酶/Akt/内皮型一氧化氮合酶途径增加迁移和管形成和分化。最后,用 WT 或 Tie2-ABCG1 小鼠的标记 EPC 静脉注射 1 型和 2 型糖尿病动脉损伤小鼠模型。通过注射 ABCG1 过表达而非 WT EPC,糖尿病小鼠的再内皮化得到了更大程度的改善。我们的研究表明,EPC 中的 ABCG1 通过增加 EPC 功能(如迁移、管形成和分化)来改善糖尿病血管损伤后的修复,从而促进随后的再内皮化。ABCG1 可能是治疗糖尿病相关血管疾病的有前途的靶点。